Follow
Nafia Guljar
Nafia Guljar
Verified email at icr.ac.uk
Title
Cited by
Cited by
Year
The adequacy of tissue microarrays in the assessment of inter-and intra-tumoural heterogeneity of infiltrating lymphocyte burden in leiomyosarcoma
ATJ Lee, W Chew, CP Wilding, N Guljar, MJ Smith, DC Strauss, C Fisher, ...
Scientific Reports 9 (1), 14602, 2019
282019
Extracting DNA from FFPE tissue biospecimens using user-friendly automated technology: is there an impact on yield or quality?
W Mathieson, N Guljar, I Sanchez, M Sroya, GA Thomas
Biopreservation and biobanking 16 (3), 191-199, 2018
182018
Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry
M Milighetti, L Krasny, ATJ Lee, G Morani, C Szecsei, Y Chen, N Guljar, ...
Journal of Proteomics 241, 104236, 2021
132021
The proteomic landscape of soft tissue sarcomas
J Burns, CP Wilding, L Krasny, X Zhu, M Chadha, YB Tam, H Ps, ...
Nature Communications 14 (1), 3834, 2023
82023
Macrophage-mediated immunoediting drives ductal carcinoma evolution: space is the game changer
C Gatenbee, J West, AM Baker, N Guljar, L Jones, TA Graham, ...
bioRxiv, 594598, 2019
72019
Proteomic profiling identifies co-regulated expression of splicing factors as a characteristic feature of intravenous leiomyomatosis
L Krasny, CP Wilding, E Perkins, A Arthur, N Guljar, AD Jenks, C Fisher, ...
Cancers 14 (12), 2907, 2022
22022
Characterisation of a Novel Cell Line (ICR-SS-1) Established from a Patient-Derived Xenograft of Synovial Sarcoma
WGJ Kerrison, J Ning, L Krasny, A Arthur, N Guljar, ML Elms, A Swain, ...
Cells 11 (15), 2418, 2022
12022
Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis. Cancers 2022, 14, 2907
L Krasny, CP Wilding, E Perkins, A Arthur, N Guljar, AD Jenks, C Fisher, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–8